Antibiotic Ban
Biological Safety & Integrity
Antibiotic Ban is a bio-safety risk scenario. It occurs when strategic market exclusion risk where zero-tolerance pharmacological 'Mirror Clauses' collide with intensive farming practices. The primary business impact is immediate Revenue Stop.
Example industry: Marine aquaculture ISIC 0321
Source: Risk Rule BIO_SAF_007 — Biological Safety & Integrity
Immediate Revenue Stop. Total seizure of shipments at entry points; permanent de-listing from high-value markets (EU/US/Japan). Remediation requires a multi-year, CAPEX-heavy transition to audited ABF production systems.
How This Risk Can Manifest
In Marine aquaculture (ISIC 0321):
Effective September 2026, the EU rejects all shrimp shipments from a major region lacking 'Lifetime-ABF' digital provenance (DT01); regional revenue drops 80% as inventory is diverted to low-value local markets at a loss.
What Triggers This Scenario
This scenario activates when all of the following GTIAS attribute thresholds are met simultaneously:
Scores drawn from the GTIAS 81-attribute scorecard. Click any attribute code to view its definition.
What To Do
Immediate steps to address or mitigate this scenario:
- Adopt 'Antibiotic-Free' (ABF) certification
- implement VAMREG-compliant digital drug logs (DT05)
- utilize precision livestock monitoring to reduce disease pressure without prophylactics.
Recommended Playbooks
These tactical playbooks are designed to directly address this risk scenario:
- Identity Preserved (IP) Supply & Molecular Segregation Quality Assurance / Strategic Compliance
Tools & Services to Address This Risk
You've seen what this scenario costs. Here are the tools that close each trigger condition before it activates — matched to the specific GTIAS attributes that trigger this scenario, ranked by how directly they address each risk condition.
QuickSigner
30,000+ active users • Enterprise-grade security, starts free
ISO 27001-certified, AATL-backed e-signatures with full audit trails give regulated industries the legally-verifiable, compliance-ready agreement execution their oversight regimes require — replacing manual paper trails that can't withstand audit scrutiny
QuickSigner is an ISO 27001-certified electronic signature platform for signing, sending, and finalizing agreements — with unlimited AATL-backed e-signatures on every plan and no per-envelope fees.
Sign and finalize agreements in minutesIndependent recommendation matched to this industry's risk profile. We may earn a commission if you purchase — this never affects matching or scores.
Common Questions
Free Analysis Brief
Get the Full Scenario Report
Download the complete analysis: extended action plan, industry benchmarks, and a curated list of solution providers for Antibiotic Ban.
Already have access? Open the brief directly →
Industries Where This Risk Triggers
2 industries have attribute scores that meet all trigger conditions for this risk scenario: